Dimensional Fund Advisors’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-18,907
| Closed | -$2.42M | – | 3281 |
|
|
2025
Q2 | $2.42M | Buy |
18,907
+303
| +2% | +$31.5K | ﹤0.01% | 2716 |
|
|
2025
Q1 | $1.65M | Sell |
18,604
-21,604
| -54% | -$2.11M | ﹤0.01% | 2766 |
|
|
2024
Q4 | $3.51M | Buy |
40,208
+1,200
| +3% | +$110K | ﹤0.01% | 2637 |
|
|
2024
Q3 | $3.61M | Buy |
39,008
+7,029
| +22% | +$698K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $3.45M | Sell |
31,979
-16,619
| -34% | -$1.66M | ﹤0.01% | 2610 |
|
|
2024
Q1 | $4.61M | Sell |
48,598
-31,381
| -39% | -$2.69M | ﹤0.01% | 2574 |
|
|
2023
Q4 | $7.38M | Sell |
79,979
-91,684
| -53% | -$5.94M | ﹤0.01% | 2444 |
|
|
2023
Q3 | $8.62M | Sell |
171,663
-112,307
| -40% | -$6M | ﹤0.01% | 2335 |
|
|
2023
Q2 | $18M | Sell |
283,970
-24,131
| -8% | -$1.31M | 0.01% | 1987 |
|
|
2023
Q1 | $13.9M | Sell |
308,101
-49,630
| -14% | -$2.24M | ﹤0.01% | 2083 |
|
|
2022
Q4 | $15.7K | Sell |
357,731
-76,725
| -18% | -$3.68M | ﹤0.01% | 1984 |
|
|
2022
Q3 | $28.6M | Sell |
434,456
-99,654
| -19% | -$6.4M | 0.01% | 1620 |
|
|
2022
Q2 | $27M | Sell |
534,110
-20,370
| -4% | -$1.19M | 0.01% | 1693 |
|
|
2022
Q1 | $35.4M | Buy |
554,480
+97,557
| +21% | +$7M | 0.01% | 1643 |
|
|
2021
Q4 | $48.9M | Buy |
456,923
+175,896
| +63% | +$18.4M | 0.01% | 1421 |
|
|
2021
Q3 | $28.9M | Buy |
281,027
+216,778
| +337% | +$20.2M | 0.01% | 1802 |
|
|
2021
Q2 | $5.65M | Buy |
64,249
+3,132
| +5% | +$287K | ﹤0.01% | 2575 |
|
|
2021
Q1 | $5.95M | Sell |
61,117
-5,745
| -9% | -$574K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $7.5M | Buy |
66,862
+24,029
| +56% | +$2.53M | ﹤0.01% | 2379 |
|
|
2020
Q3 | $3.97M | Buy |
42,833
+39,864
| +1,343% | +$3.07M | ﹤0.01% | 2519 |
|
|
2020
Q2 | $232K | Sell |
2,969
-21,470
| -88% | -$1.45M | ﹤0.01% | 3194 |
|
|
2020
Q1 | $1.43M | Sell |
24,439
-658
| -3% | -$42.3K | ﹤0.01% | 2809 |
|
|
2019
Q4 | $2.01M | Sell |
25,097
-462
| -2% | -$34.6K | ﹤0.01% | 2852 |
|
|
2019
Q3 | $1.88M | Buy |
25,559
+16,318
| +177% | +$1.41M | ﹤0.01% | 2867 |
|
|
2019
Q2 | $872K | Sell |
9,241
-2,894
| -24% | -$239K | ﹤0.01% | 3082 |
|
|
2019
Q1 | $971K | Sell |
12,135
-12,942
| -52% | -$956K | ﹤0.01% | 3040 |
|
|
2018
Q4 | $1.35M | Buy |
+25,077
| New | +$1.52M | ﹤0.01% | 2955 |
|
|
2018
Q2 | – | Sell |
-42,965
| Closed | -$3.94M | – | 3369 |
|
|
2018
Q1 | $3.94M | Buy |
+42,965
| New | +$3.7M | ﹤0.01% | 2703 |
|
Other funds holding BPMC
IA
HNB
Dimensional Fund Advisors's BPMC Position: Q3 2025 in Review
Dimensional Fund Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 18,907 shares — an estimated $2.42M sold.
Dimensional Fund Advisors first reported a position in BPMC in Q1 2018 and held it in 28 quarters. The position peaked at $48.9M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Dimensional Fund Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Dimensional Fund Advisors sold 18,907 Blueprint Medicines shares in Q3 2025, an estimated $2.42M.
- Dimensional Fund Advisors first reported a position in Blueprint Medicines in Q1 2018 and held it in 28 quarters.
- Dimensional Fund Advisors's Blueprint Medicines position peaked at $48.9M in Q4 2021.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.